000 01292 a2200337 4500
005 20250517235454.0
264 0 _c20181001
008 201810s 0 0 eng d
022 _a1744-7666
024 7 _a10.1080/14656566.2018.1519021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHall, Ronald G
245 0 0 _aAn evaluation of tedizolid for the treatment of MRSA infections.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cSep 2018
300 _a1489-1494 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLinezolid
_xtherapeutic use
650 0 4 _aMethicillin-Resistant Staphylococcus aureus
_xdrug effects
650 0 4 _aOxazolidinones
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSoft Tissue Infections
_xdrug therapy
650 0 4 _aStaphylococcal Infections
_xdrug therapy
650 0 4 _aTetrazoles
_xtherapeutic use
700 1 _aSmith, Winter J
700 1 _aPutnam, William C
700 1 _aPass, Steven E
773 0 _tExpert opinion on pharmacotherapy
_gvol. 19
_gno. 13
_gp. 1489-1494
856 4 0 _uhttps://doi.org/10.1080/14656566.2018.1519021
_zAvailable from publisher's website
999 _c28821336
_d28821336